Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan; Drug: Telmisartan in combination with hydrochlorothiazide

Study type: Observational

Funder types: Industry

Identifiers

NCT02242383

502.485

Details and patient eligibility

About

To evaluate efficacy and tolerability of Micardis® / MicardisPlus® under usual daily-practice prescribing conditions with a special emphasis on controlling morning blood pressure

Enrollment: 13,248 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years, insufficiently treated hypertension

Exclusion criteria

• Age < 18 years

Trial design

13,248 participants in 1 patient group

Essential hypertension

Treatment:

Drug: Telmisartan

Drug: Telmisartan in combination with hydrochlorothiazide